⌘K

Login Start Free

Home/Filings/4/0001567619-21-012669

4//SEC Filing

KABAKOFF DAVID S 4

Accession 0001567619-21-012669

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 6:15 PM ET

Size

5.4 KB

Accession

0001567619-21-012669

Insider Transaction Report

Form 4

Period: 2021-06-24

NextCure, Inc.NXTC

KABAKOFF DAVID S

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-24+14,250→ 14,250 total
Exercise: $8.21Exp: 2031-06-23→ Common Stock (14,250 underlying)

Footnotes (1)

[F1]The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

IncorporatedCA

Related Parties

1

filerCIK 0001024008

Filing Metadata

Form type: 4
Filed: Jun 27, 8:00 PM ET
Accepted: Jun 28, 6:15 PM ET
Size: 5.4 KB

View on SEC.gov